GILD vs ABBV: Which Stock is Better?
Side-by-side comparison of Gilead Sciences Inc and AbbVie Inc in 2026
GILD
Gilead Sciences Inc
$131.03
ABBV
AbbVie Inc
$248.08
Key Metrics Comparison
| Metric | GILD | ABBV | Winner |
|---|---|---|---|
| Market Cap | $160.15B | $334.34B | ABBV |
| P/E Ratio | 17.55 | 80.54 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze GILD
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GILD or ABBV a better investment?
Comparing GILD and ABBV: Gilead Sciences Inc has a market cap of $160.15B while AbbVie Inc has $334.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GILD and ABBV?
GILD (Gilead Sciences Inc) and ABBV (AbbVie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GILD or ABBV?
Based on P/E ratios, GILD trades at a lower multiple (17.5x vs 80.5x).
Which is growing faster: GILD or ABBV?
Both GILD and ABBV show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: GILD or ABBV?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: GILD or ABBV?
AbbVie Inc (ABBV) is larger with a market cap of $334.34B compared to $160.15B for GILD.
Should I buy GILD or ABBV in 2026?
Both GILD and ABBV have investment merit. GILD trades at $131.03 while ABBV trades at $248.08. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GILD and ABBV stock?
Key differences: Market Cap ($160.15B vs $334.34B), P/E Ratio (17.5x vs 80.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy GILD or ABBV in 2026?
The choice between GILD and ABBV depends on your investment goals. ABBV shows higher revenue growth (0.0%). ABBV has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between GILD and ABBV?
GILD (Gilead Sciences Inc) has a market cap of $160.15B, while ABBV (AbbVie Inc) has a market cap of $334.34B. ABBV is the larger company by market value.